← 產業報告目錄
Bispecific Antibody Drug Industry Research Report 2026
出版商 APO Research產業別 Healthcare & Life Sciences出版日期 2026-01-02頁數 126報告編號 APO-0e8f0a7488
授權報價
| Single User | $2,950 USD |
| Multi User | $4,430 USD |
| Enterprise | $5,900 USD |
報告摘要
The global Bispecific Antibody Drug market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the Bispecific Antibody Drug market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Bispecific Antibody Drug market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Bispecific Antibody Drug market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Bispecific Antibody Drug include Affimed, Akeso, Alphamab, BeiGene, Genmab, Immunocore Limited, Lindis Biotech, MacroGenics and Xencor, among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Bispecific Antibody Drug market in terms of revenue (US$ million) and, where applicable, service volume (K Units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Bispecific Antibody Drug.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Bispecific Antibody Drug Market by Company
Affimed
Akeso
Alphamab
BeiGene
Genmab
Immunocore Limited
Lindis Biotech
MacroGenics
Xencor
AstraZeneca
Abbvie
Amgen
Pfizer
Roche
Merck
Johnson & Johnson
Sanofi
Bispecific Antibody Drug Segment by Type
Fragment-Based
IgG-Based
Bispecific Antibody Drug Segment by Application
Cancer
Haemophilia
Other Diseases
Bispecific Antibody Drug Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Bispecific Antibody Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Bispecific Antibody Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Bispecific Antibody Drug.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Bispecific Antibody Drug companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
目錄 Table of Contents
1 Preface
1.1 Scope of Report
1.2 Reasons for Doing This Study
1.3 Research Methodology
1.4 Research Process
1.5 Data Source
1.5.1 Secondary Sources
1.5.2 Primary Sources
2 Market Overview
2.1 Product Definition
2.2 Bispecific Antibody Drug by Type
2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
2.2.2 Fragment-Based
2.2.3 IgG-Based
2.3 Bispecific Antibody Drug by Application
2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
2.3.2 Cancer
2.3.3 Haemophilia
2.3.4 Other Diseases
2.4 Assumptions and Limitations
3 Bispecific Antibody Drug Breakdown Data by Type
3.1 Global Bispecific Antibody Drug Historic Market Size by Type (2021-2026)
3.2 Global Bispecific Antibody Drug Forecasted Market Size by Type (2027-2032)
4 Bispecific Antibody Drug Breakdown Data by Application
4.1 Global Bispecific Antibody Drug Historic Market Size by Application (2021-2026)
4.2 Global Bispecific Antibody Drug Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
5.1 Global Bispecific Antibody Drug Market Perspective (2021-2032)
5.2 Global Bispecific Antibody Drug Growth Trends by Region
5.2.1 Global Bispecific Antibody Drug Market Size by Region: 2021 VS 2025 VS 2032
5.2.2 Bispecific Antibody Drug Historic Market Size by Region (2021-2026)
5.2.3 Bispecific Antibody Drug Forecasted Market Size by Region (2027-2032)
5.3 Bispecific Antibody Drug Market Dynamics
5.3.1 Bispecific Antibody Drug Industry Trends
5.3.2 Bispecific Antibody Drug Market Drivers
5.3.3 Bispecific Antibody Drug Market Challenges
5.3.4 Bispecific Antibody Drug Market Restraints
6 Market Competitive Landscape by Players
6.1 Global Top Bispecific Antibody Drug Players by Revenue
6.1.1 Global Top Bispecific Antibody Drug Players by Revenue (2021-2026)
6.1.2 Global Bispecific Antibody Drug Revenue Market Share by Players (2021-2026)
6.2 Global Bispecific Antibody Drug Industry Players Ranking, 2023 VS 2024 VS 2025
6.3 Global Key Players of Bispecific Antibody Drug Head Office and Area Served
6.4 Global Bispecific Antibody Drug Players, Product Type & Application
6.5 Global Bispecific Antibody Drug Manufacturers Established Date
6.6 Global Bispecific Antibody Drug Market CR5 and HHI
6.7 Global Players Mergers & Acquisition
7 North America
7.1 North America Bispecific Antibody Drug Market Size (2021-2032)
7.2 North America Bispecific Antibody Drug Market Growth Rate by Country: 2021 VS 2025 VS 2032
7.3 North America Bispecific Antibody Drug Market Size by Country (2021-2026)
7.4 North America Bispecific Antibody Drug Market Size by Country (2027-2032)
7.5 United States
7.5 United States
7.6 Canada
7.7 Mexico
8 Europe
8.1 Europe Bispecific Antibody Drug Market Size (2021-2032)
8.2 Europe Bispecific Antibody Drug Market Growth Rate by Country: 2021 VS 2025 VS 2032
8.3 Europe Bispecific Antibody Drug Market Size by Country (2021-2026)
8.4 Europe Bispecific Antibody Drug Market Size by Country (2027-2032)
8.5 Germany
8.6 France
8.7 U.K.
8.8 Italy
8.9 Spain
8.10 Russia
8.11 Netherlands
8.12 Nordic Countries
9 Asia-Pacific
9.1 Asia-Pacific Bispecific Antibody Drug Market Size (2021-2032)
9.2 Asia-Pacific Bispecific Antibody Drug Market Growth Rate by Country: 2021 VS 2025 VS 2032
9.3 Asia-Pacific Bispecific Antibody Drug Market Size by Country (2021-2026)
9.4 Asia-Pacific Bispecific Antibody Drug Market Size by Country (2027-2032)
9.5 China
9.6 Japan
9.7 South Korea
9.8 India
9.9 Australia
9.10 China Taiwan
9.11 Southeast Asia
10 South America
10.1 South America Bispecific Antibody Drug Market Size (2021-2032)
10.2 South America Bispecific Antibody Drug Market Growth Rate by Country: 2021 VS 2025 VS 2032
10.3 South America Bispecific Antibody Drug Market Size by Country (2021-2026)
10.4 South America Bispecific Antibody Drug Market Size by Country (2027-2032)
10.5 Brazil
10.6 Argentina
10.7 Chile
10.8 Colombia
10.9 Peru
11 Middle East & Africa
11.1 Middle East & Africa Bispecific Antibody Drug Market Size (2021-2032)
11.2 Middle East & Africa Bispecific Antibody Drug Market Growth Rate by Country: 2021 VS 2025 VS 2032
11.3 Middle East & Africa Bispecific Antibody Drug Market Size by Country (2021-2026)
11.4 Middle East & Africa Bispecific Antibody Drug Market Size by Country (2027-2032)
11.5 Saudi Arabia
11.6 Israel
11.7 United Arab Emirates
11.8 Turkey
11.9 Iran
11.10 Egypt
12 Players Profiled
12.1 Affimed
12.1.1 Affimed Company Information
12.1.2 Affimed Business Overview
12.1.3 Affimed Revenue in Bispecific Antibody Drug Business (2021-2026)
12.1.4 Affimed Bispecific Antibody Drug Product Portfolio
12.1.5 Affimed Recent Developments
12.2 Akeso
12.2.1 Akeso Company Information
12.2.2 Akeso Business Overview
12.2.3 Akeso Revenue in Bispecific Antibody Drug Business (2021-2026)
12.2.4 Akeso Bispecific Antibody Drug Product Portfolio
12.2.5 Akeso Recent Developments
12.3 Alphamab
12.3.1 Alphamab Company Information
12.3.2 Alphamab Business Overview
12.3.3 Alphamab Revenue in Bispecific Antibody Drug Business (2021-2026)
12.3.4 Alphamab Bispecific Antibody Drug Product Portfolio
12.3.5 Alphamab Recent Developments
12.4 BeiGene
12.4.1 BeiGene Company Information
12.4.2 BeiGene Business Overview
12.4.3 BeiGene Revenue in Bispecific Antibody Drug Business (2021-2026)
12.4.4 BeiGene Bispecific Antibody Drug Product Portfolio
12.4.5 BeiGene Recent Developments
12.5 Genmab
12.5.1 Genmab Company Information
12.5.2 Genmab Business Overview
12.5.3 Genmab Revenue in Bispecific Antibody Drug Business (2021-2026)
12.5.4 Genmab Bispecific Antibody Drug Product Portfolio
12.5.5 Genmab Recent Developments
12.6 Immunocore Limited
12.6.1 Immunocore Limited Company Information
12.6.2 Immunocore Limited Business Overview
12.6.3 Immunocore Limited Revenue in Bispecific Antibody Drug Business (2021-2026)
12.6.4 Immunocore Limited Bispecific Antibody Drug Product Portfolio
12.6.5 Immunocore Limited Recent Developments
12.7 Lindis Biotech
12.7.1 Lindis Biotech Company Information
12.7.2 Lindis Biotech Business Overview
12.7.3 Lindis Biotech Revenue in Bispecific Antibody Drug Business (2021-2026)
12.7.4 Lindis Biotech Bispecific Antibody Drug Product Portfolio
12.7.5 Lindis Biotech Recent Developments
12.8 MacroGenics
12.8.1 MacroGenics Company Information
12.8.2 MacroGenics Business Overview
12.8.3 MacroGenics Revenue in Bispecific Antibody Drug Business (2021-2026)
12.8.4 MacroGenics Bispecific Antibody Drug Product Portfolio
12.8.5 MacroGenics Recent Developments
12.9 Xencor
12.9.1 Xencor Company Information
12.9.2 Xencor Business Overview
12.9.3 Xencor Revenue in Bispecific Antibody Drug Business (2021-2026)
12.9.4 Xencor Bispecific Antibody Drug Product Portfolio
12.9.5 Xencor Recent Developments
12.10 AstraZeneca
12.10.1 AstraZeneca Company Information
12.10.2 AstraZeneca Business Overview
12.10.3 AstraZeneca Revenue in Bispecific Antibody Drug Business (2021-2026)
12.10.4 AstraZeneca Bispecific Antibody Drug Product Portfolio
12.10.5 AstraZeneca Recent Developments
12.11 Abbvie
12.11.1 Abbvie Company Information
12.11.2 Abbvie Business Overview
12.11.3 Abbvie Revenue in Bispecific Antibody Drug Business (2021-2026)
12.11.4 Abbvie Bispecific Antibody Drug Product Portfolio
12.11.5 Abbvie Recent Developments
12.12 Amgen
12.12.1 Amgen Company Information
12.12.2 Amgen Business Overview
12.12.3 Amgen Revenue in Bispecific Antibody Drug Business (2021-2026)
12.12.4 Amgen Bispecific Antibody Drug Product Portfolio
12.12.5 Amgen Recent Developments
12.13 Pfizer
12.13.1 Pfizer Company Information
12.13.2 Pfizer Business Overview
12.13.3 Pfizer Revenue in Bispecific Antibody Drug Business (2021-2026)
12.13.4 Pfizer Bispecific Antibody Drug Product Portfolio
12.13.5 Pfizer Recent Developments
12.14 Roche
12.14.1 Roche Company Information
12.14.2 Roche Business Overview
12.14.3 Roche Revenue in Bispecific Antibody Drug Business (2021-2026)
12.14.4 Roche Bispecific Antibody Drug Product Portfolio
12.14.5 Roche Recent Developments
12.15 Merck
12.15.1 Merck Company Information
12.15.2 Merck Business Overview
12.15.3 Merck Revenue in Bispecific Antibody Drug Business (2021-2026)
12.15.4 Merck Bispecific Antibody Drug Product Portfolio
12.15.5 Merck Recent Developments
12.16 Johnson & Johnson
12.16.1 Johnson & Johnson Company Information
12.16.2 Johnson & Johnson Business Overview
12.16.3 Johnson & Johnson Revenue in Bispecific Antibody Drug Business (2021-2026)
12.16.4 Johnson & Johnson Bispecific Antibody Drug Product Portfolio
12.16.5 Johnson & Johnson Recent Developments
12.17 Sanofi
12.17.1 Sanofi Company Information
12.17.2 Sanofi Business Overview
12.17.3 Sanofi Revenue in Bispecific Antibody Drug Business (2021-2026)
12.17.4 Sanofi Bispecific Antibody Drug Product Portfolio
12.17.5 Sanofi Recent Developments
13 Report Conclusion
14 Disclaimer
圖表清單 List of Tables & Figures
List of Tables
Table 1. Secondary Sources
Table 2. Primary Sources
Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million)
Table 5. Global Bispecific Antibody Drug Market Size by Type (2021-2026) & (US$ Million)
Table 6. Global Bispecific Antibody Drug Revenue Market Share by Type (2021-2026)
Table 7. Global Bispecific Antibody Drug Forecasted Market Size by Type (2027-2032) & (US$ Million)
Table 8. Global Bispecific Antibody Drug Revenue Market Share by Type (2027-2032)
Table 9. Global Bispecific Antibody Drug Market Size by Application (2021-2026) & (US$ Million)
Table 10. Global Bispecific Antibody Drug Revenue Market Share by Application (2021-2026)
Table 11. Global Bispecific Antibody Drug Forecasted Market Size by Application (2027-2032) & (US$ Million)
Table 12. Global Bispecific Antibody Drug Revenue Market Share by Application (2027-2032)
Table 13. Global Bispecific Antibody Drug Market Size by Region (US$ Million): 2021 VS 2025 VS 2032
Table 14. Global Bispecific Antibody Drug Market Size by Region (2021-2026) & (US$ Million)
Table 15. Global Bispecific Antibody Drug Market Share by Region (2021-2026)
Table 16. Global Bispecific Antibody Drug Forecasted Market Size by Region (2027-2032) & (US$ Million)
Table 17. Global Bispecific Antibody Drug Market Share by Region (2027-2032)
Table 18. Bispecific Antibody Drug Industry Trends
Table 19. Bispecific Antibody Drug Industry Drivers
Table 20. Bispecific Antibody Drug Industry Opportunities and Challenges
Table 21. Bispecific Antibody Drug Market Restraints
Table 22. Global Top Bispecific Antibody Drug Players by Revenue (US$ Million) & (2021-2026)
Table 23. Global Bispecific Antibody Drug Revenue Market Share by Players (2021-2026)
Table 24. Global Bispecific Antibody Drug Industry Players Ranking, 2024 VS 2025 VS 2026
Table 25. Global Key Players of Bispecific Antibody Drug, Headquarters and Area Served
Table 26. Global Bispecific Antibody Drug Players, Product Type & Application
Table 27. Global Players Market Concentration Ratio (CR5 and HHI)
Table 28. Global Bispecific Antibody Drug by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025)
Table 29. Players Mergers & Acquisitions, Expansion Plans
Table 30. North America Bispecific Antibody Drug Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 31. North America Bispecific Antibody Drug Market Size by Country (2021-2026) & (US$ Million)
Table 32. North America Bispecific Antibody Drug Market Size by Country (2027-2032) & (US$ Million)
Table 33. Europe Bispecific Antibody Drug Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 34. Europe Bispecific Antibody Drug Market Size by Country (2021-2026) & (US$ Million)
Table 35. Europe Bispecific Antibody Drug Market Size by Country (2027-2032) & (US$ Million)
Table 36. Asia Pacific Bispecific Antibody Drug Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 37. Asia Pacific Bispecific Antibody Drug Market Size by Region (2021-2026) & (US$ Million)
Table 38. Asia Pacific Bispecific Antibody Drug Market Size by Country (2027-2032) & (US$ Million)
Table 39. South America Bispecific Antibody Drug Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 40. South America Bispecific Antibody Drug Market Size by Country (2021-2026) & (US$ Million)
Table 41. South America Bispecific Antibody Drug Market Size by Country (2027-2032) & (US$ Million)
Table 42. Middle East & Africa Bispecific Antibody Drug Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 43. Middle East & Africa Bispecific Antibody Drug Market Size by Country (2021-2026) & (US$ Million)
Table 44. Middle East & Africa Bispecific Antibody Drug Market Size by Country (2027-2032) & (US$ Million)
Table 45. Affimed Company Information
Table 46. Affimed Business Overview
Table 47. Affimed Revenue in Bispecific Antibody Drug Business (2021-2026) & (US$ Million)
Table 48. Affimed Bispecific Antibody Drug Product Portfolio
Table 49. Affimed Recent Developments
Table 50. Akeso Company Information
Table 51. Akeso Business Overview
Table 52. Akeso Revenue in Bispecific Antibody Drug Business (2021-2026) & (US$ Million)
Table 53. Akeso Bispecific Antibody Drug Product Portfolio
Table 54. Akeso Recent Developments
Table 55. Alphamab Company Information
Table 56. Alphamab Business Overview
Table 57. Alphamab Revenue in Bispecific Antibody Drug Business (2021-2026) & (US$ Million)
Table 58. Alphamab Bispecific Antibody Drug Product Portfolio
Table 59. Alphamab Recent Developments
Table 60. BeiGene Company Information
Table 61. BeiGene Business Overview
Table 62. BeiGene Revenue in Bispecific Antibody Drug Business (2021-2026) & (US$ Million)
Table 63. BeiGene Bispecific Antibody Drug Product Portfolio
Table 64. BeiGene Recent Developments
Table 65. Genmab Company Information
Table 66. Genmab Business Overview
Table 67. Genmab Revenue in Bispecific Antibody Drug Business (2021-2026) & (US$ Million)
Table 68. Genmab Bispecific Antibody Drug Product Portfolio
Table 69. Genmab Recent Developments
Table 70. Immunocore Limited Company Information
Table 71. Immunocore Limited Business Overview
Table 72. Immunocore Limited Revenue in Bispecific Antibody Drug Business (2021-2026) & (US$ Million)
Table 73. Immunocore Limited Bispecific Antibody Drug Product Portfolio
Table 74. Immunocore Limited Recent Developments
Table 75. Lindis Biotech Company Information
Table 76. Lindis Biotech Business Overview
Table 77. Lindis Biotech Revenue in Bispecific Antibody Drug Business (2021-2026) & (US$ Million)
Table 78. Lindis Biotech Bispecific Antibody Drug Product Portfolio
Table 79. Lindis Biotech Recent Developments
Table 80. MacroGenics Company Information
Table 81. MacroGenics Business Overview
Table 82. MacroGenics Revenue in Bispecific Antibody Drug Business (2021-2026) & (US$ Million)
Table 83. MacroGenics Bispecific Antibody Drug Product Portfolio
Table 84. MacroGenics Recent Developments
Table 85. Xencor Company Information
Table 86. Xencor Business Overview
Table 87. Xencor Revenue in Bispecific Antibody Drug Business (2021-2026) & (US$ Million)
Table 88. Xencor Bispecific Antibody Drug Product Portfolio
Table 89. Xencor Recent Developments
Table 90. AstraZeneca Company Information
Table 91. AstraZeneca Business Overview
Table 92. AstraZeneca Revenue in Bispecific Antibody Drug Business (2021-2026) & (US$ Million)
Table 93. AstraZeneca Bispecific Antibody Drug Product Portfolio
Table 94. AstraZeneca Recent Developments
Table 95. Abbvie Company Information
Table 96. Abbvie Business Overview
Table 97. Abbvie Revenue in Bispecific Antibody Drug Business (2021-2026) & (US$ Million)
Table 98. Abbvie Bispecific Antibody Drug Product Portfolio
Table 99. Abbvie Recent Developments
Table 100. Amgen Company Information
Table 101. Amgen Business Overview
Table 102. Amgen Revenue in Bispecific Antibody Drug Business (2021-2026) & (US$ Million)
Table 103. Amgen Bispecific Antibody Drug Product Portfolio
Table 104. Amgen Recent Developments
Table 105. Pfizer Company Information
Table 106. Pfizer Business Overview
Table 107. Pfizer Revenue in Bispecific Antibody Drug Business (2021-2026) & (US$ Million)
Table 108. Pfizer Bispecific Antibody Drug Product Portfolio
Table 109. Pfizer Recent Developments
Table 110. Roche Company Information
Table 111. Roche Business Overview
Table 112. Roche Revenue in Bispecific Antibody Drug Business (2021-2026) & (US$ Million)
Table 113. Roche Bispecific Antibody Drug Product Portfolio
Table 114. Roche Recent Developments
Table 115. Merck Company Information
Table 116. Merck Business Overview
Table 117. Merck Revenue in Bispecific Antibody Drug Business (2021-2026) & (US$ Million)
Table 118. Merck Bispecific Antibody Drug Product Portfolio
Table 119. Merck Recent Developments
Table 120. Johnson & Johnson Company Information
Table 121. Johnson & Johnson Business Overview
Table 122. Johnson & Johnson Revenue in Bispecific Antibody Drug Business (2021-2026) & (US$ Million)
Table 123. Johnson & Johnson Bispecific Antibody Drug Product Portfolio
Table 124. Johnson & Johnson Recent Developments
Table 125. Sanofi Company Information
Table 126. Sanofi Business Overview
Table 127. Sanofi Revenue in Bispecific Antibody Drug Business (2021-2026) & (US$ Million)
Table 128. Sanofi Bispecific Antibody Drug Product Portfolio
Table 129. Sanofi Recent Developments
Table 130. Authors List of This Report
List of Figures
Figure 1. Research Methodology
Figure 2. Research Process
Figure 3. Key Executives Interviewed
Figure 4. Bispecific Antibody Drug Product Image
Figure 5. Global Bispecific Antibody Drug Market Size Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
Figure 6. Global Bispecific Antibody Drug Market Share by Type: 2025 VS 2032
Figure 7. Fragment-Based Product
Figure 8. IgG-Based Product
Figure 9. Global Bispecific Antibody Drug Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million)
Figure 10. Global Bispecific Antibody Drug Market Share by Application: 2025 VS 2032
Figure 11. Cancer Product
Figure 12. Haemophilia Product
Figure 13. Other Diseases Product
Figure 14. Global Bispecific Antibody Drug Market Size (US$ Million), Year-over-Year: 2021-2032
Figure 15. Global Bispecific Antibody Drug Market Size, (US$ Million), 2021 VS 2025 VS 2032
Figure 16. Global Bispecific Antibody Drug Market Share by Region: 2025 VS 2032
Figure 17. Global Bispecific Antibody Drug Market Share by Players in 2025
Figure 18. Global Bispecific Antibody Drug Manufacturers Established Date
Figure 19. Global Top 5 and 10 Bispecific Antibody Drug Players Market Share by Revenue in 2025
Figure 20. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025
Figure 21. North America Bispecific Antibody Drug Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 22. North America Bispecific Antibody Drug Market Share by Country (2021-2032)
Figure 23. United States Bispecific Antibody Drug Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 24. Canada Bispecific Antibody Drug Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 25. Mexico Bispecific Antibody Drug Market Share by Country (2021-2032)
Figure 26. Europe Bispecific Antibody Drug Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 27. Europe Bispecific Antibody Drug Market Share by Country (2021-2032)
Figure 28. Germany Bispecific Antibody Drug Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 29. France Bispecific Antibody Drug Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 30. U.K. Bispecific Antibody Drug Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 31. Italy Bispecific Antibody Drug Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 32. Spain Bispecific Antibody Drug Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 33. Russia Bispecific Antibody Drug Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 34. Netherlands Bispecific Antibody Drug Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 35. Nordic Countries Bispecific Antibody Drug Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 36. Asia-Pacific Bispecific Antibody Drug Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 37. Asia-Pacific Bispecific Antibody Drug Market Share by Country (2021-2032)
Figure 38. China Bispecific Antibody Drug Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 39. Japan Bispecific Antibody Drug Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 40. South Korea Bispecific Antibody Drug Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 41. India Bispecific Antibody Drug Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 42. India Bispecific Antibody Drug Market Share by Country (2021-2032)
Figure 43. Australia Bispecific Antibody Drug Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 44. China Taiwan Bispecific Antibody Drug Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 45. Southeast Asia Bispecific Antibody Drug Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 46. South America Bispecific Antibody Drug Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 47. South America Bispecific Antibody Drug Market Share by Country (2021-2032)
Figure 48. Brazil Bispecific Antibody Drug Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 49. Argentina Bispecific Antibody Drug Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 50. Chile Bispecific Antibody Drug Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 51. Colombia Bispecific Antibody Drug Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 52. Peru Bispecific Antibody Drug Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 53. Affimed Revenue Growth Rate in Bispecific Antibody Drug Business (2021-2026)
Figure 54. Akeso Revenue Growth Rate in Bispecific Antibody Drug Business (2021-2026)
Figure 55. Alphamab Revenue Growth Rate in Bispecific Antibody Drug Business (2021-2026)
Figure 56. BeiGene Revenue Growth Rate in Bispecific Antibody Drug Business (2021-2026)
Figure 57. Genmab Revenue Growth Rate in Bispecific Antibody Drug Business (2021-2026)
Figure 58. Immunocore Limited Revenue Growth Rate in Bispecific Antibody Drug Business (2021-2026)
Figure 59. Lindis Biotech Revenue Growth Rate in Bispecific Antibody Drug Business (2021-2026)
Figure 60. MacroGenics Revenue Growth Rate in Bispecific Antibody Drug Business (2021-2026)
Figure 61. Xencor Revenue Growth Rate in Bispecific Antibody Drug Business (2021-2026)
Figure 62. AstraZeneca Revenue Growth Rate in Bispecific Antibody Drug Business (2021-2026)
Figure 63. Abbvie Revenue Growth Rate in Bispecific Antibody Drug Business (2021-2026)
Figure 64. Amgen Revenue Growth Rate in Bispecific Antibody Drug Business (2021-2026)
Figure 65. Pfizer Revenue Growth Rate in Bispecific Antibody Drug Business (2021-2026)
Figure 66. Roche Revenue Growth Rate in Bispecific Antibody Drug Business (2021-2026)
Figure 67. Merck Revenue Growth Rate in Bispecific Antibody Drug Business (2021-2026)
Figure 68. Johnson & Johnson Revenue Growth Rate in Bispecific Antibody Drug Business (2021-2026)
Figure 69. Sanofi Revenue Growth Rate in Bispecific Antibody Drug Business (2021-2026)
提及公司
AffimedAkesoAlphamabBeiGeneGenmabImmunocore LimitedLindis BiotechMacroGenicsXencorAstraZenecaAbbvieAmgenPfizerRocheMerckJohnson & JohnsonSanofi
量子訊息有限公司為 APO Research 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們